David Boucher has worked in healthcare for 45 years; he currently serves as Chief Partnerships Officer at Bumrungrad International Hospital in Bangkok, Thailand.

David served for the two years prior to January 2023 as Chief of Service Excellence and Medical Value Travel (MVT) at the corporate level with Dubai-based Aster DM Healthcare. From June 2018 until June 2020, David served as Chief Business Transformation Officer at Bumrungrad. Between 2000 and 2017, he served in several capacities as an executive of the insurance company BlueCross Blue Shield of South Carolina. From 2012-2017, David served as President of UCI Medical Affiliates in Columbia, SC – managing 80 retail medical care centers- treating over 740,000 patients in 2017. From 2006 through 2016, Mr. Boucher concurrently served as President of Companion Global Healthcare, Inc. – the world’s only medical tourism facilitator owned by a major health insurer. Prior to 2000, David served as CEO at several hospitals in the United States.

Mr. Boucher earned his BS degree from Slippery Rock University (Pennsylvania) and a Master of Public Health from the University of South Carolina; he has been named a distinguished alumnus by both institutions.

David has been quoted in over 250 newspapers and journals, including The Wall Street Journal, New York Times, The Economist, and U.S. News & World Reports. He has been interviewed on NBC Nightly News and Fox Business News. He has delivered lectures on disruptive innovation in healthcare at Harvard Business School, Yale School of Management, and Harvard Medical School.

Abie is Vice President of Statistical Consulting at Premier Research, a leading clinical research organization in the biotechnology space, where he brings expertise in advanced clinical trial designs and provides strategic direction in optimizing drug development programs.

With over 30 years of experience, Abie has worked in different capacities around the globe – in the pharmaceutical industry, academia, and within the international organization system. During his over 22 years in pharma, he has held several senior technical and senior leadership positions. Before that, he was Lecturer in Statistics at Macquarie University in Sydney, Australia, and previously worked as a research scientist with the World Health Organization in Geneva, Switzerland.

As a strategic technical leader, he has led, overseen and consulted on multiple global drug development programs across a range of diseases and participated in several FDA advisory meetings. He has served on data monitoring boards and was an at-large advisor to the executive committee of the Biopharmaceutical Section of the American Statistical Association. Driven by his interest in leadership development, Abie founded the Section’s Leadership-in-Practice Committee. In addition, while in Australia, he was Chair of the Australian Pharmaceutical Biostatistics Group (APBG), which he founded. He is passionate about leadership development and continues to serve as a dedicated mentor within the ASA BioPharmaceutical Section.

Abie earned his doctorate and masters degrees from the University of Southampton, UK, and more recently, impelled by his interests in the business of healthcare innovation, he completed a mini-MBA in BioPharma Innovation through Rutgers Business School.

As an investor, Abie focuses his interests on the healthcare space, where he places keen emphasis on investments that help bring global access to treatment for patients who need them.

David is a serial entrepreneur, writer, adviser, and early-stage fund manager with over thirty years of experience in creating and building software technology companies.

After failing at retirement twice, David became the Triangle’s most active angel investor spending his time as a volunteer coach and mentor to startup founders and managing a free accelerator he sponsors with the Town of Cary. To combat the lack of early-stage capital in NC, David created and runs Cofounders Capital, a $12M seed fund, the success of which led to a second $31M fund.

As an entrepreneur, David was the founder or co-founder of seven companies, including PeopleClick (purchased for $100 million) and Report2Web, which sold for $12M in less than eleven months from inception. He has demonstrated a record for consistency across multiple industries with six successful exits in a row… and one he refuses to talk about.

David served as the Executive VP and Thought Leader for Compuware, a Fortune 1000 Corporation, after it acquired ProviderLink, a healthcare IT exchange he founded.

As a writer, David is the author of a popular book on entrepreneurship called The StartUp Hats. He has published many articles and forward-thinking white papers on technical innovation, entrepreneurship, and economic development. Among other firsts, David is credited with founding and launching the first software-as-a-service venture in NC.

As a lifelong learner, David is constantly researching new technologies and challenging traditional ways of thinking. In addition to several years of full-time computer science and business-related postgraduate studies at NCSU, Mr. Gardner holds degrees in Philosophy and Music with a postgraduate concentration in theology and dead languages. What drives David today is his passion for helping smart, coachable, first-time entrepreneurs build their businesses, watching them succeed, and witnessing their life-changing transformations.

Bob Greczyn retired on February 1, 2010, as chief executive officer of Blue Cross and Blue Shield of North Carolina, the state’s largest health insurer. Greczyn joined the company in 1998, bringing 20 years of leadership experience in healthcare and a solid understanding of the North Carolina healthcare market.

In his role at BCBSNC, Greczyn served on both the Board of Trustees for BCBSNC and on the board of the National Blue Cross and Blue Shield Association. He was the chairman of the board of directors for The Council for Affordable Quality Healthcare (CAQH), an alliance of the nation’s leading health plans working on simplifying healthcare transactions.

Greczyn serves on many boards, from healthcare organizations to higher education. He is also the owner of several Mellow Mushroom franchises and Fortnight Brewery in Cary. Greczyn earned a Master of Public Health from the University of North Carolina at Chapel Hill and a Bachelor of Arts in psychology from East Carolina University. He also completed the executive program in healthcare finance management at the University of North Carolina at Chapel Hill.

Maureen O’Connor is an entrepreneur and healthcare industry veteran passionate about driving transformational change in our healthcare system to improve access, health, and well-being through scalable technology, delivery redesign, and payment innovation.

Currently, Maureen serves as CEO of ZealCare, a tech-enabled healthcare services company spun out of Duke, with a mission to empower individuals with complex chronic conditions to make necessary lifestyle changes to allow therapeutics to work and to live a more vigorous life. Through a highly scalable virtual platform, the company provides intensive, personalized coaching and peer support to participants

Prior to her role with ZealCare, Maureen served as president of Whiterabbit.ai, an early-stage Silicon Valley company with a mission to eradicate late-stage breast cancer using artificial intelligence. Before joining Whiterabbit.ai, Maureen spent 17 years as an executive with Blue Cross Blue Shield North Carolina, serving as executive vice president of diversified businesses and president of Mosaic Health Solutions, the corporate venture arm of the company (now Echo Health Ventures); chief strategy and innovation officer; chief administrative officer; and general counsel.

Maureen serves in board and advisory roles for a number of healthcare technology, biotech, and investment companies. She currently chairs the board of APIE Therapeutics and serves on the board of Carolina Angel Network. She is a venture partner with Spring Tide Ventures and is a founding member of OnBoardNC. During the past decade, Maureen has been active on many professional and community boards.
​
She received a law degree from Suffolk University Law School and a bachelor’s degree in English from the College of the Holy Cross. In her free time, Maureen enjoys traveling, hiking, and photography and is a regular contributor to LinkedIn, writing posts that integrate lessons of leadership, life, and photography.

Leo Spector, MD, MBA, is a practicing orthopedic spine surgeon at Orthocarolina in Charlotte, NC. He previously served as the practices’ chief quality officer overseeing its value-based care program. He currently serves on the board of directors of the lumbar spine research society, where he chairs the ethics committee.

Additionally, Dr. Spector is a member of the cervical spine research society and a fellow of the American academy of orthopedic surgeons and the American Orthopedic association. He also served as the spine fellowship co-director at Orthocarolina and is the past president of the North Carolina spine society.

Dr. Spector earned his medical degree from the University of Massachusetts medical school, where he then completed his internship in general surgery and residency in orthopedic surgery. Following residency, he completed a one-year fellowship in spine surgery at the Orthocarolina spine center. He completed the North Carolina physician institute for quality enhancement program (NCPIQE) through the North Carolina medical society (NCMS). He earned his MBA from Duke Fuqua School of Business.

President of Balestrand Strategic Advisors. Maureen Sullivan provides senior advisory and facilitation services to Boards, CEOs, and C-Suite executives. With over 30 years of experience, most recently as Chief Strategy and Innovation Officer for the Blue Cross Blue Shield Association (BCBSA), Maureen has worked with senior leadership in all 50 states and Puerto Rico across different sectors, including healthcare, business, and government.

At Balestrand Strategic Advisors, Maureen has worked with several early-stage companies to accelerate growth and strengthen strategic positioning. The companies share the fundamental drive to improve the quality and affordability of healthcare. Maureen is also helping Civica on the market access strategy for the first insulin products with transparent pricing.

In her position at BCBSA, Maureen developed the strategic partnerships group that spearheaded the development of new market solutions, including CivicaScript, GeoBlue, and Blue Health Intelligence. She fostered partnerships with major consumer companies entering healthcare and other innovators striving to improve healthcare. During her tenure, Maureen also oversaw a broad range of functions, including strategy, communications, brand marketing, group purchasing ($1.5B in spend), educational programs, and international.

Maureen has served on many Boards and Advisory Committees, including the CivicaRx Board (Finance Committee) and the GeoBlue Board (Chair of CEO Search Committee; Chair of Strategy Committee). Maureen graduated with a Master’s in Public Policy from the Harvard Kennedy School and a BA with honors from Albertus Magnus College.